{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:09:38Z","timestamp":1790838578701,"version":"4.1.0"},"reference-count":75,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Fondazione Camillo Golgi and Fondazione DiMartino"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>STAT proteins are a family of transcription factors that mediate cellular response to cytokines and growth factors. Study of patients with familial susceptibility to pathogens and\/or autoimmune diseases has led to the identification of 7 inherited disorders that are caused by mutations of 4 STAT family genes. Homozygous or compound heterozygous mutations of STAT1 lead to complete or partial forms of STAT1 deficiency that are associated with susceptibility to intracellular pathogens and herpetic infections. Patients with heterozygous STAT1 gain-of-function (GOF) mutations usually present with chronic mucocutaneous candidiasis (CMC) but may also experience bacterial and viral infections, autoimmune manifestations, lymphopenia, cerebral aneurysms, and increased risk to develop tumors. STAT2 deficiency has been described in 5 family members and is characterized by selective susceptibility to viral infections, whereas STAT3 loss-of-function (LOF) mutations are causative of the autosomal-dominant hyper-IgE syndrome (HIES), a condition that is characterized by cutaneous and respiratory infections in association with mucocutaneous candidiasis, eczema, skeletal and connective tissue abnormalities, eosinophilia, and high levels IgE. STAT5B LOF and STAT3 GOF mutations are both associated with disorders characterized by autoimmune or allergic manifestations, together with increased risk of infections. Particularly, STAT5b deficiency results in growth hormone (GH) insensitivity, immunodeficiency, diarrhea, and generalized eczema, whereas STAT3 GOF mutations result in autoimmune cytopenia, lymphadenopathy, short stature, infections, enteropathy, and multiorgan autoimmunity, including early-onset type I diabetes, thyroiditis, hepatitis, arthritis, and interstitial lung disease.<\/jats:p>","DOI":"10.1189\/jlb.5ri0516-237rr","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T01:43:42Z","timestamp":1478051022000},"page":"29-38","source":"Crossref","is-referenced-by-count":65,"title":["STAT mutations as program switchers: turning primary immunodeficiencies into autoimmune diseases"],"prefix":"10.1093","volume":"101","author":[{"given":"Tiziana","family":"Lorenzini","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Sciences, Institute of Molecular Medicine \u201cAngelo Nocivelli,\u201d University of Brescia , Brescia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dotta","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, Institute of Molecular Medicine \u201cAngelo Nocivelli,\u201d University of Brescia , Brescia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Giacomelli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, Institute of Molecular Medicine \u201cAngelo Nocivelli,\u201d University of Brescia , Brescia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Vairo","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, Institute of Molecular Medicine \u201cAngelo Nocivelli,\u201d University of Brescia , Brescia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Badolato","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, Institute of Molecular Medicine \u201cAngelo Nocivelli,\u201d University of Brescia , Brescia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,11,1]]},"reference":[{"key":"2023011712044895400_B1","doi-asserted-by":"crossref","first-page":"20059","DOI":"10.1074\/jbc.R700016200","article-title":"JAK-STAT signaling: from interferons to cytokines","volume":"282","author":"Schindler","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2023011712044895400_B2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The JAK-STAT pathway at twenty","volume":"36","author":"Stark","year":"2012","journal-title":"Immunity"},{"key":"2023011712044895400_B3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK-STAT pathway: impact on human disease and therapeutic intervention","volume":"66","author":"O\u2019Shea","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"2023011712044895400_B4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMra1202117","article-title":"JAKs and STATs in immunity, immunodeficiency, and cancer","volume":"368","author":"O\u2019Shea","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"2023011712044895400_B5","doi-asserted-by":"crossref","first-page":"22328","DOI":"10.1074\/jbc.M110.123299","article-title":"CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4","volume":"285","author":"Bankovich","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2023011712044895400_B6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity","volume":"26","author":"Bustamante","year":"2014","journal-title":"Semin. Immunol."},{"key":"2023011712044895400_B7","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI0215770","article-title":"IFNs and STATs in innate immunity to microorganisms","volume":"109","author":"Decker","year":"2002","journal-title":"J. Clin. Invest."},{"key":"2023011712044895400_B8","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2011-01-330571","article-title":"Severe impairment of IFN-\u03b3 and IFN-\u03b1 responses in cells of a patient with a novel STAT1 splicing mutation","volume":"118","author":"Vairo","year":"2011","journal-title":"Blood"},{"key":"2023011712044895400_B9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.coi.2012.04.011","article-title":"Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes","volume":"24","author":"Boisson-Dupuis","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"2023011712044895400_B10","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2006.09.052","article-title":"Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics","volume":"131","author":"Marcello","year":"2006","journal-title":"Gastroenterology"},{"key":"2023011712044895400_B11","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa0907206","article-title":"Inflammatory bowel disease and mutations affecting the interleukin-10 receptor","volume":"361","author":"Glocker","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"2023011712044895400_B12","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.4049\/jimmunol.0901383","article-title":"Dendritic cells require STAT-1 phosphorylated at its transactivating domain for the induction of peptide-specific CTL","volume":"183","author":"Pilz","year":"2009","journal-title":"J. Immunol."},{"key":"2023011712044895400_B13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ng1097","article-title":"Impaired response to interferon-alpha\/beta and lethal viral disease in human STAT1 deficiency","volume":"33","author":"Dupuis","year":"2003","journal-title":"Nat. Genet."},{"key":"2023011712044895400_B14","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.4049\/jimmunol.176.8.5078","article-title":"Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo","volume":"176","author":"Chapgier","year":"2006","journal-title":"J. Immunol."},{"key":"2023011712044895400_B15","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1172\/JCI37083","article-title":"A partial form of recessive STAT1 deficiency in humans","volume":"119","author":"Chapgier","year":"2009","journal-title":"J. Clin. Invest."},{"key":"2023011712044895400_B16","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1182\/blood-2010-04-280586","article-title":"A novel form of human STAT1 deficiency impairing early but not late responses to interferons","volume":"116","author":"Kong","year":"2010","journal-title":"Blood"},{"key":"2023011712044895400_B17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10875-010-9480-8","article-title":"Novel STAT1 alleles in a patient with impaired resistance to mycobacteria","volume":"31","author":"Kristensen","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"2023011712044895400_B18","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1371\/journal.pgen.0020131","article-title":"Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease","volume":"2","author":"Chapgier","year":"2006","journal-title":"PLoS Genet."},{"key":"2023011712044895400_B19","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/humu.22113","article-title":"Dominant-negative STAT1 SH2 domain mutations in unrelated patients with Mendelian susceptibility to mycobacterial disease","volume":"33","author":"Tsumura","year":"2012","journal-title":"Hum. Mutat."},{"key":"2023011712044895400_B20","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/j.ijid.2011.01.004","article-title":"Molecular immunity to mycobacteria: knowledge from the mutation and phenotype spectrum analysis of Mendelian susceptibility to mycobacterial diseases","volume":"15","author":"Qu","year":"2011","journal-title":"Int. J. Infect. Dis."},{"key":"2023011712044895400_B21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1100102","article-title":"STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis","volume":"365","author":"Van de Veerdonk","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"2023011712044895400_B22","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20110958","article-title":"Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis","volume":"208","author":"Liu","year":"2011","journal-title":"J. Exp. Med."},{"key":"2023011712044895400_B23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10875-015-0214-9","article-title":"The extended clinical phenotype of 26 patients with chronic mucocutaneous candidiasis due to gain-of-function mutations in STAT1","volume":"36","author":"Depner","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"2023011712044895400_B24","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jaci.2013.01.004","article-title":"Gain-of-function STAT1 mutations are associated with PD-L1 overexpression and a defect in B-cell survival","volume":"131","author":"Romberg","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"2023011712044895400_B25","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1002\/eji.201445344","article-title":"Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)","volume":"45","author":"Zheng","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"2023011712044895400_B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2015.12.010","article-title":"Clinical heterogeneity of dominant chronic mucocutaneous candidiasis disease: presenting as treatment-resistant candidiasis and chronic lung disease","volume":"164","author":"Dotta","year":"2016","journal-title":"Clin. Immunol."},{"key":"2023011712044895400_B27","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"2023011712044895400_B28","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jaci.2013.01.052","article-title":"Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis","volume":"131","author":"Sampaio","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"2023011712044895400_B29","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jaci.2012.11.054","article-title":"Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome","volume":"131","author":"Uzel","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"2023011712044895400_B30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.gene.2016.04.006","article-title":"Common variable immunodeficiency, impaired neurological development and reduced numbers of T regulatory cells in a 10-year-old boy with a STAT1 gain-of-function mutation","volume":"586","author":"Kobbe","year":"2016","journal-title":"Gene"},{"key":"2023011712044895400_B31","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jaci.2013.09.032","article-title":"Fatal combined immunodeficiency associated with heterozygous mutation in STAT1","volume":"133","author":"Sharfe","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"2023011712044895400_B32","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2014.05.044","article-title":"Gain-of-function mutations in signal transducer and activator of transcription 1 (STAT1): chronic mucocutaneous candidiasis accompanied by enamel defects and delayed dental shedding","volume":"134","author":"Frans","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"2023011712044895400_B33","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1073\/pnas.1220098110","article-title":"STAT2 deficiency and susceptibility to viral illness in humans","volume":"110","author":"Hambleton","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023011712044895400_B34","doi-asserted-by":"crossref","first-page":"e23435","DOI":"10.4161\/jkst.23435","article-title":"STAT3 and the hyper-IgE syndrome: clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties","volume":"2","author":"Mogensen","year":"2013","journal-title":"JAK-STAT"},{"key":"2023011712044895400_B35","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1073\/pnas.94.8.3801","article-title":"Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality","volume":"94","author":"Takeda","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023011712044895400_B36","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/hep.27968","article-title":"Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma","volume":"62","author":"Won","year":"2015","journal-title":"Hepatology"},{"key":"2023011712044895400_B37","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2141.2006.06468.x","article-title":"Bruton\u2019s tyrosine kinase prevents activation of the anti-apoptotic transcription factor STAT3 and promotes apoptosis in neoplastic B-cells and B-cell precursors exposed to oxidative stress","volume":"136","author":"Uckun","year":"2007","journal-title":"Br. J. Haematol."},{"key":"2023011712044895400_B38","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1172\/JCI0215650","article-title":"What does Stat3 do","volume":"109","author":"Levy","year":"2002","journal-title":"J. Clin. Invest."},{"key":"2023011712044895400_B39","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","article-title":"The JAK-STAT signaling pathway: input and output integration","volume":"178","author":"Murray","year":"2007","journal-title":"J. Immunol."},{"key":"2023011712044895400_B40","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jaci.2009.10.059","article-title":"Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome","volume":"125","author":"Woellner","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"2023011712044895400_B41","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jaci.2016.04.020","article-title":"Elucidating the effects of disease-causing mutations on STAT3 function in autosomal-dominant hyper-IgE syndrome","volume":"138","author":"Pelham","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"2023011712044895400_B42","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1002\/eji.201141721","article-title":"SH2-domain mutations in STAT3 in hyper-IgE syndrome patients result in impairment of IL-10 function","volume":"41","author":"Giacomelli","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"2023011712044895400_B43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaci.2008.04.037","article-title":"Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome","volume":"122","author":"Renner","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"2023011712044895400_B44","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"key":"2023011712044895400_B45","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"2023011712044895400_B46","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"key":"2023011712044895400_B47","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1084\/jem.20080321","article-title":"Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells","volume":"205","author":"De Beaucoudrey","year":"2008","journal-title":"J. Exp. Med."},{"key":"2023011712044895400_B48","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20080218","article-title":"Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3","volume":"205","author":"Ma","year":"2008","journal-title":"J. Exp. Med."},{"key":"2023011712044895400_B49","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"2023011712044895400_B50","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10875-016-0278-1","article-title":"The potential and limits of hematopoietic stem cell transplantation for the treatment of autosomal dominant hyper-IgE syndrome","volume":"36","author":"Yanagimachi","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"2023011712044895400_B51","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1084\/jem.20100799","article-title":"Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells","volume":"208","author":"Saito","year":"2011","journal-title":"J. Exp. Med."},{"key":"2023011712044895400_B52","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","article-title":"Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey","volume":"91","author":"Chandesris","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"2023011712044895400_B53","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.immuni.2011.09.016","article-title":"A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory","volume":"35","author":"Siegel","year":"2011","journal-title":"Immunity"},{"key":"2023011712044895400_B54","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1182\/blood-2013-06-506865","article-title":"IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts","volume":"122","author":"Berglund","year":"2013","journal-title":"Blood"},{"key":"2023011712044895400_B55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1172\/JCI19491","article-title":"Stat-3 is required for pulmonary homeostasis during hyperoxia","volume":"113","author":"Hokuto","year":"2004","journal-title":"J. Clin. Invest."},{"key":"2023011712044895400_B56","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jaci.2015.05.021","article-title":"A neuropathological study of cerebrovascular abnormalities in a signal transducer and activator of transcription 3-deficient patient","volume":"136","author":"Chandesris","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"2023011712044895400_B57","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nm1425","article-title":"Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury","volume":"12","author":"Okada","year":"2006","journal-title":"Nat. Med."},{"key":"2023011712044895400_B58","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.bbrc.2005.01.019","article-title":"Osteoporosis with increased osteoclastogenesis in hematopoietic cell-specific STAT3-deficient mice","volume":"328","author":"Zhang","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2023011712044895400_B59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCGENETICS.111.961235","article-title":"Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency","volume":"5","author":"Chandesris","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"2023011712044895400_B60","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat. Genet."},{"key":"2023011712044895400_B61","first-page":"591","volume-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","author":"Milner","year":"2015"},{"key":"2023011712044895400_B62","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","article-title":"Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3","volume":"125","author":"Haapaniemi","year":"2015","journal-title":"Blood"},{"key":"2023011712044895400_B63","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/eji.200737193","article-title":"Deficient SOCS3 expression in CD4+CD25+FoxP3+ regulatory T cells and SOCS3-mediated suppression of Treg function","volume":"37","author":"Pillemer","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"2023011712044895400_B64","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s10875-014-0038-z","article-title":"Elevated double negative T cells in pediatric autoimmunity","volume":"34","author":"Tarbox","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"2023011712044895400_B65","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"2023011712044895400_B66","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.20110283","article-title":"Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas","volume":"208","author":"Pilati","year":"2011","journal-title":"J. Exp. Med."},{"key":"2023011712044895400_B67","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.immuni.2012.03.016","article-title":"Inborn errors of human JAKs and STATs","volume":"36","author":"Casanova","year":"2012","journal-title":"Immunity"},{"key":"2023011712044895400_B68","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.beem.2010.09.003","article-title":"STAT5b deficiency: lessons from STAT5b gene mutations","volume":"25","author":"Hwa","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"2023011712044895400_B69","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa022926","article-title":"Growth hormone insensitivity associated with a STAT5b mutation","volume":"349","author":"Kofoed","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"2023011712044895400_B70","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.clim.2013.04.014","article-title":"Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells","volume":"148","author":"Jenks","year":"2013","journal-title":"Clin. Immunol."},{"key":"2023011712044895400_B71","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ghir.2015.12.006","article-title":"STAT5B deficiency: impacts on human growth and immunity","volume":"28","author":"Hwa","year":"2016","journal-title":"Growth Horm. IGF Res."},{"key":"2023011712044895400_B72","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/ACI.0b013e328358cc0b","article-title":"Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis","volume":"12","author":"Puel","year":"2012","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"2023011712044895400_B73","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrd4088","article-title":"Therapeutic modulators of STAT signalling for human diseases","volume":"12","author":"Miklossy","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"2023011712044895400_B74","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1002\/eji.201445344","article-title":"Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)","volume":"45","author":"Smeekens","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"Suppl","key":"2023011712044895400_B75","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.jinf.2016.04.023","article-title":"Treatment options for chronic mucocutaneous candidiasis","volume":"72","author":"Van de Veerdonk","year":"2016","journal-title":"J. Infect."}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/101\/1\/29\/48719398\/jlb0029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/101\/1\/29\/48719398\/jlb0029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T13:36:59Z","timestamp":1677505019000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/101\/1\/29\/6933023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,1]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,11,1]]},"published-print":{"date-parts":[[2017,1,1]]}},"URL":"https:\/\/doi.org\/10.1189\/jlb.5ri0516-237rr","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,1]]},"published":{"date-parts":[[2016,11,1]]}}}